Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke: QuICR & OPTIMISE Registry Based Pragmatic Randomized Controlled Trial

NCT03889249 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT03889249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke: QuICR & OPTIMISE Registry Based Pragmatic Randomized Controlled Trial
Lead sponsor
University of Calgary
Phase
Phase 3
Overall status
Completed
Start date
December 10, 2019
Completion date
April 30, 2023
Enrollment
1,600 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute, thromboses, intracranial